相关实验视频

Updated: Jun 12, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

胃癌治疗中的黑色素:我们在哪里?

Mahdi Rafiyan^1,2, Elham Tootoonchi^1,2, Mahdieh Golpour³

¹Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.

Naunyn-Schmiedeberg's archives of pharmacology

|September 17, 2024

概括

黑素是一种天然化合物,通过抑制瘤生长和扩散,在治疗胃癌 (GC) 中表现有前途. 进一步研究黑激素的研究.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

胃癌 (GC) 是一个重要的全球健康问题,排名为癌症相关死亡的主要原因.
在之前的研究中,黑素已经证明对胃癌细胞的增殖,进展和入侵有抑制作用.
微RNA (miRNA) 是基因表达的关键调节者,而黑激素对GC中的外体miRNA的影响是一个新兴的研究领域.

研究的目的:

全面审查和综合现有的体内和体外数据关于黑激素在胃癌中的治疗作用.
阐明基因组中黑色素抗癌活性背后的分子机制.
评估黑激素作为胃癌治疗新型治疗剂的潜力.

主要方法:

系统审查和分析已发表的体内和体外研究.
在胃癌模型中评估受黑激素影响的分子信号通路.
综合证据关于黑激素对癌细胞增殖,细胞亡,化疗耐药性,血管新生和转移的影响.

主要成果:

黑色素通过准多个信号通路,对抗胃癌具有多方面的治疗潜力.
关键的机制包括抑制癌细胞增殖,诱导细胞灭绝和减少化疗耐药性.
黑色素还在限制胃癌细胞的侵袭,血管生成和转移方面表现出有效性.

结论:

黑色素在通过各种分子机制控制胃癌的进展方面发挥着至关重要的作用.
这些发现支持黑素作为胃癌的有希望和可测试的治疗剂.
需要进一步对黑激素在GC治疗中的疗效和安全性进行临床研究.

关键词:

胃癌胃癌是指胃癌.机制机制机制黑色素是什么黑色素是什么黑色素是什么有针对性的治疗.

更多相关视频

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice

Published on: April 16, 2018

相关概念视频

Management of Insomnia

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...